Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/67256
Title: | The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project |
Author: | Borràs Andrés, Josep Maria Barton, Michael Grau, Cai Corral, Julieta Verhoeven, Rob Lemmens, Valery Eycken, Liesbet van Henau, Kris Primic-Zakelj, Maja Strojan, Primoz Trojanowski, Maciej Dyzmann-Sroka, Agnieszka Kubiak, Anna Gasparotto, Chiara Defourny, Noémie Malicki, Julian Dunscombe, Peter Coffey, Mary Lievens, Yolande |
Keywords: | Gestió hospitalària Gestió de personal Radioteràpia Europa Enquestes Radiologia Equipaments sanitaris Hospital administration Personnel management Radiotherapy Europe Surveys Radiology Health facilities |
Issue Date: | 1-Jul-2015 |
Publisher: | Elsevier B.V. |
Abstract: | Background and purpose: The impact of differences in the distribution of major cancer sites and stages at diagnosis among 4 European countries on the optimal utilization proportion (OUP) of patients who should receive external beam radiotherapy was assessed within the framework of the ESTRO-HERO project. Materials and methods: Data from Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used. Population based stages at diagnosis from the cancer registries of Belgium, Slovenia, the Greater Poland region of Poland, and The Netherlands were used to assess the OUP for each country. A sensitivity analysis was carried out. Results: The overall OUP by country varied from the lowest of 48.3% in Australia to the highest of 53.4% in Poland; among European countries the variation was limited to 3%. Cancer site specific OUPs showed differences according to the variability in stage at diagnosis across countries. The most important impact on the OUP by country was due to changes in relative frequency of tumours rather than stage at diagnosis. Conclusions: This methodology can be adapted using European data, thus facilitating the planning of resources required to cope with the demand for radiotherapy in Europe, taking into account the national variability in cancer incidence. |
Note: | Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.radonc.2015.04.021 |
It is part of: | Radiotherapy and Oncology, 2015, vol. 116, num. 1, p. 45-50 |
URI: | http://hdl.handle.net/2445/67256 |
Related resource: | http://dx.doi.org/10.1016/j.radonc.2015.04.021 |
ISSN: | 0167-8140 |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
652921.pdf | 425.84 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.